Rating History for TCR2 Therapeutics (TCRR) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for TCRR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/19/2022 Madhu Kumar New Coverage Neutral
(N/A)		 5.00
(N/A)		 4.01
(2.89)		 -27.93% Details